Search Results - "Giuliani, E. A"
-
1
Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor
Published in Science (American Association for the Advancement of Science) (25-06-1993)“…To acquire transforming potential, the precursor of the Ras oncoprotein must undergo farnesylation of the cysteine residue located in a carboxyl-terminal…”
Get full text
Journal Article -
2
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton
Published in Molecular and Cellular Biology (01-06-1994)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
3
L-687,908, a potent hydroxyethylene containing HIV protease inhibitor
Published in Journal of medicinal chemistry (01-03-1991)Get full text
Journal Article -
4
Potent, non-thiol inhibitors of farnesyltransferase
Published in Bioorganic & medicinal chemistry letters (01-12-1998)“…The structure-activity relationship of a series of non-thiol CaaX analogs, which are inhibitors of farnesyltransferase, is described. These inhibitors contain…”
Get full text
Journal Article -
5
N-Arylalkyl Pseudopeptide Inhibitors of Farnesyltransferase
Published in Journal of medicinal chemistry (02-07-1998)“…Inhibitors of Ras protein farnesyltransferase are described which are reduced pseudopeptides related to the C-terminal tetrapeptide of the Ras protein that…”
Get full text
Journal Article -
6
NMR studies of novel inhibitors bound to farnesyl‐protein transferase
Published in Protein science (01-04-1995)“…Farnesyl‐protein transferase (FPTase) catalyzes the posttranslational farnesylation of the cysteine residue located in the carboxyl‐terminal tetrapeptide of…”
Get full text
Journal Article -
7
Pseudodipeptide Inhibitors of Protein Farnesyltransferase
Published in Journal of medicinal chemistry (29-09-1995)“…A series of pseudodipeptide amides are described that inhibit Ras protein farnesyltransferase (PFTase). These inhibitors are truncated versions of the…”
Get full text
Journal Article -
8
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity
Published in Journal of medicinal chemistry (01-07-1992)“…A series of HIV-1 protease inhibitors containing a novel hydroxyethyl secondary amine transition state isostere has been synthesized. The compounds exhibit a…”
Get full text
Journal Article -
9
Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679
Published in Journal of medicinal chemistry (01-09-1991)“…A series of tetrapeptide analogues of 1 (L-682,679), in which the carboxy terminus has been shortened and modified, was prepared and their inhibitory activity…”
Get full text
Journal Article -
10
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
Published in Journal of medicinal chemistry (01-01-1995)“…We have observed a high correlation between the intermolecular interaction energy (Einter) calculated for HIV-1 protease inhibitor complexes and the observed…”
Get full text
Journal Article -
11
Pseudopeptide inhibitors of Ras farnesyl-protein transferase
Published in Journal of medicinal chemistry (18-03-1994)“…Inhibitors of Ras farnesyl-protein transferase are described. These are reduced pseudopeptides related to the C-terminal tetrapeptide of the Ras protein that…”
Get full text
Journal Article -
12
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice
Published in Nature medicine (01-08-1995)“…For Ras oncoproteins to transform mammalian cells, they must be post-translationally modified with a farnesyl group in a reaction catalysed by the enzyme…”
Get full text
Journal Article -
13
-
14
Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation
Published in Circulation (New York, N.Y.) (16-04-2002)“…Endothelin-1 (ET-1), a potent vasoconstrictor, is released in response to several inflammatory cytokines after heart transplantation. The present study…”
Get full text
Journal Article -
15
-
16
A Priori Prediction of Activity for HIV-1 Protease Inhibitors Employing Energy Minimization in the Active Site
Published in Journal of medicinal chemistry (24-05-1996)Get full text
Journal Article